Survival after neoadjuvant versus adjuvant chemotherapy in operable hormone receptor-positive HER2-negative breast cancer
Year: 2026
Type: article
Study design: Observational Study
Abstract: Neoadjuvant chemotherapy (NACT) can facilitate tumor downstaging in operable hormone receptor-positive/ human epidermal growth factor receptor 2 (HER2)-negative breast cancer, whereas comparisons of long-term outcome with adjuvant chemotherapy (ACT) inform treatment selection. We compared NACT and ACT in a multicenter retrospective cohort of 2,355 women treated at five Chinese centers between 2013 and 2019. Inverse probability of treatment weighting was used to improve the balance of measured baseline characteristics. After weighting, NACT was associated with shorter disease-free survival (hazard ratio [HR] 1.73, 95% confidence interval [CI] 1.26–2.37, p = 0.001) and overall survival (HR 1.85, 95% CI 1.18–2.90, p = 0.007) compared with ACT. Among patients receiving NACT, adverse associations with survival were more pronounced in clinical nonresponders than in responders. These observational findings suggest that post-treatment clinical response may help stratify prognosis after NACT and support the consideration of baseline risk and expected response when selecting the chemotherapy sequence.
Source: iScience
Authors: Qiao Cheng(Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Resources, Supervision, Validation, Writing – original draft), Yirui Wei(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft), Xueyi Hou(Conceptualization, Formal analysis, Investigation, Methodology, Resources, Validation, Writing – original draft), Hongyuan Li(Conceptualization, Data curation, Investigation, Project administration, Resources, Supervision, Writing – original draft), Xinmiao Yu(Conceptualization, Data curation, Investigation, Resources, Supervision, Writing – original draft), Jie Chen(Conceptualization, Data curation, Investigation, Resources, Supervision, Writing – original draft), Mengyuan Wang(Conceptualization, Data curation, Investigation, Resources, Supervision, Writing – original draft), Ming Li(Conceptualization, Data curation, Investigation, Resources, Supervision, Writing – original draft), Yifeng Li(Conceptualization, Data curation, Investigation, Resources, Supervision, Writing – original draft), Chaoyang Li(Conceptualization, Data curation, Investigation, Resources, Supervision, Writing – original draft), Jia Ming(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft), Xiaowei Qi(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft), Lu Gan(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft)
Institutions: The Affiliated Yongchuan Hospital of Chongqing Medical University, First Hospital of China Medical University, Sichuan University, West China Hospital of Sichuan University, Chongqing Three Gorges Central Hospital, Chongqing Medical University, Second Affiliated Hospital of Chongqing Medical University, Army Medical University, Southwest Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,240
Award: G4427435602
OpenAlex ID: W7235118689
